3 Profitable Stocks That Fall Short

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.

Not all profitable companies are created equal, and that’s why we built StockStory - to help you find the ones that truly shine bright. Keeping that in mind, here are three profitable companies that don’t make the cut and some better opportunities instead.

Entegris (ENTG)

Trailing 12-Month GAAP Operating Margin: 16%

With fabs representing the company’s largest customer type, Entegris (NASDAQ:ENTG) supplies products that purify, protect, and generally ensure the integrity of raw materials needed for advanced semiconductor manufacturing.

Why Are We Cautious About ENTG?

1. Sales were flat over the last two years, indicating it’s failed to expand this cycle
2. Estimated sales growth of 15.2% for the next 12 months is soft and implies weaker demand
3. Ability to fund investments or reward shareholders with increased buybacks or dividends is restricted by its weak free cash flow margin of 12.8% for the last two years

Entegris is trading at $162.67 per share, or 36.1x forward P/E. If you’re considering ENTG for your portfolio, see our FREE research report to learn more.

Amneal (AMRX)

Trailing 12-Month GAAP Operating Margin: 14.6%

Founded in 2002 and growing into one of America's largest generic drug producers, Amneal Pharmaceuticals (NASDAQ:AMRX) develops, manufactures, and distributes generic medicines, specialty branded drugs, biosimilars, and injectable products for the U.S. healthcare market.

Why Are We Hesitant About AMRX?

1. Estimated sales growth of 3.3% for the next 12 months implies demand will slow from its two-year trend
2. Annual earnings per share growth of 4.8% underperformed its revenue over the last five years, showing its incremental sales were less profitable
3. Below-average returns on capital indicate management struggled to find compelling investment opportunities

At $18.30 per share, Amneal trades at 18.3x forward P/E. Read our free research report to see why you should think twice about including AMRX in your portfolio.

Murphy Oil (MUR)

Trailing 12-Month GAAP Operating Margin: 18.5%

Operating in waters over a mile deep in the Gulf of Mexico and extracting hydrocarbons from tight shale rock formations in Texas, Murphy Oil (NYSE:MUR) explores for and produces crude oil, natural gas, and natural gas liquids from fields in North America and Asia.

Why Does MUR Give Us Pause?

1. Day-to-day expenses have swelled relative to revenue over the last five years as its EBITDA margin fell by 4.3 percentage points

Murphy Oil’s stock price of $34.70 implies a valuation ratio of 12.9x forward P/E. Check out our free in-depth research report to learn more about why MUR doesn’t pass our bar.

High-Quality Stocks for All Market Conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.